Search

Author/Creator Ribadeneira, Maria D.

3. Safety, Pharmacokinetics, and Pharmacodynamics of Etavopivat (FT‐4202), an Allosteric Activator of Pyruvate Kinase‐R, in Healthy Adults: A Randomized, Placebo‐Controlled, Double‐Blind, First‐in‐Human Phase 1 Trial. Issue 5 (12th January 2022)

Authors:
Forsyth, Sanjeev; Schroeder, Patricia; Geib, James; Vrishabhendra, Leela; Konstantinidis, Diamantis G.; LaSalvia, Kari; Ribadeneira, Maria D.; Wu, Eric; Kelly, Patrick; Kalfa, Theodosia A.
Journal:
Clinical pharmacology in drug development
Issue:
Volume 11:Issue 5(2022)
Page Start:
654
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗